Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP582661.RA8oYxdTKF3Xh1dYou2344ut--jNeMQlKkmNkX4lM8Gd8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP582661.RA8oYxdTKF3Xh1dYou2344ut--jNeMQlKkmNkX4lM8Gd8130_assertion type Assertion NP582661.RA8oYxdTKF3Xh1dYou2344ut--jNeMQlKkmNkX4lM8Gd8130_head.
- NP582661.RA8oYxdTKF3Xh1dYou2344ut--jNeMQlKkmNkX4lM8Gd8130_assertion wasGeneratedBy ECO_0000203 NP582661.RA8oYxdTKF3Xh1dYou2344ut--jNeMQlKkmNkX4lM8Gd8130_provenance.
- NP582661.RA8oYxdTKF3Xh1dYou2344ut--jNeMQlKkmNkX4lM8Gd8130_assertion wasDerivedFrom befree-20140225 NP582661.RA8oYxdTKF3Xh1dYou2344ut--jNeMQlKkmNkX4lM8Gd8130_provenance.
- NP582661.RA8oYxdTKF3Xh1dYou2344ut--jNeMQlKkmNkX4lM8Gd8130_assertion SIO_000772 10978257 NP582661.RA8oYxdTKF3Xh1dYou2344ut--jNeMQlKkmNkX4lM8Gd8130_provenance.
- NP582661.RA8oYxdTKF3Xh1dYou2344ut--jNeMQlKkmNkX4lM8Gd8130_assertion evidence source_evidence_literature NP582661.RA8oYxdTKF3Xh1dYou2344ut--jNeMQlKkmNkX4lM8Gd8130_provenance.
- NP582661.RA8oYxdTKF3Xh1dYou2344ut--jNeMQlKkmNkX4lM8Gd8130_assertion description "[No significant differences were found in the therapeutic response of PON1 activity between genotype groups (8.5% and 11.1% increase for QQ homozygous and R-carrier FH patients, respectively, and 12.7% and 9.5% increase for LL homozygotes and M carriers, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP582661.RA8oYxdTKF3Xh1dYou2344ut--jNeMQlKkmNkX4lM8Gd8130_provenance.